Cargando…

Evaluation of Pharmacokinetic Feasibility of Febuxostat/L-pyroglutamic Acid Cocrystals in Rats and Mice

Febuxostat (FBX), a selective xanthine oxidase inhibitor, belongs to BCS class II, showing low solubility and high permeability with a moderate F value (<49%). Recently, FBX/L-pyroglutamic acid cocrystal (FBX-PG) was developed with an improving 4-fold increase of FBX solubility. Nevertheless, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jeong-Eun, You, Byoung Hoon, Bae, Mingoo, Han, Seung Yon, Jung, Kiwon, Choi, Young Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459842/
https://www.ncbi.nlm.nih.gov/pubmed/37631381
http://dx.doi.org/10.3390/pharmaceutics15082167

Ejemplares similares